Complex karyotypic abnormalities in MYC, the activation of NRAS and KRAS, mutations in TP53, and inactivation of CDKN2A and CDKN2C are late-onset translocations and gene mutations that promote a higher rate of progression to MM [12,13]. Here, TP53 is linked to Miyoshi myopathy.